Clinical Trial Update: Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients

View source ↗

Summary

Clinical trial update for cemiplimab in combination with platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer in US adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Advanced Non-small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING